Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Carl de Moor, Michael Reynolds, Franz Och, and more


Inform Genomics has tapped Carl de Moor to be its chief technology officer.

Prior to joining Inform Genomics, de Moor held several roles at IMS Health, where he designed and directed retrospective epidemiologic research. He has also had several executive roles in industry including serving as VP of epidemiology at MAPI, a late-phase contract research organization; executive director of epidemiology and health outcomes at PPD; and VP of health outcomes and pharmacoeconomics at Supportive Oncology Services.

Eagle Genomics has hired Michael Reynolds to be its VP of global sales. Prior to joining Eagle, Reynolds was director for EMEA sales at Pilgrim Software. Before that, he worked at Smart Analyst, APC Pharma, and Etrials.

Also, William Spooner has been promoted to chief scientific officer, and Glenn Proctor is now the company's chief technical officer.

Human Longevity has hired Franz Och to serve as its chief data scientist. He comes to the company from Google where he was a research scientist and headed Google Translate. Before that he was a researcher in the Information Sciences Institute at the University of Southern California.

Shikha O'Brien is now Dotmatics' vice president of strategic sales and marketing. In her new role she will work on expanding Dotmatics' user base and on establishing new markets and strategic alliances

Dotmatics has also hired Rusty Irving as the head of its North American operations. Prior to joining Dotmatics, Irving was vice president of global sales at PerkinElmer. In this role, he managed the company's informatics sales efforts in the Americas, EMEA, and Asia Pacific, and served on the company's executive management team.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.